|
New Organization Created to Promote Strong IP Rights «
https://www.filewrapper.com/new-organization-created-to-promote-strong-ip-rights
filewrapper.com
|
11 |
6 |
140 |
www.c4ip.org
http://www.c4ip.org/
DOFOLLOW
|
|
Emperor Biden’s Latest — The State Goes Marching In To Seize Patents | CDN
https://conservativedailynews.com/2024/01/emperor-bidens-latest-the-state-goes-marching-in-to-seize-patents
conservativedailynews.com
|
20 |
80 |
3,337 |
Bayh-Dole Act
https://c4ip.org/wp-content/uploads/2023/12/Issue-Brief_-The-Bayh-Dole-Act-and-March-In-Rights.pdf
DOFOLLOW
|
|
The Revolving Door Threatens the Integrity of the U.S. Patent and Trademark O...
https://mjzanon.com/brazilian-ip-news/the-revolving-door-threatens-the-integrity-of-the-u-s-patent-and-trademark-office
mjzanon.com
|
— |
0 |
229 |
opposition
https://c4ip.org/the-council-for-innovation-promotion-releases-statement-on-ira-price-negotiation-list
DOFOLLOW
|
|
I-MAK Exposed - Setting the Record Straight on the Medical Innovation System
https://i-makexposed.com/
i-makexposed.com
|
— |
0 |
8 |
C4IP
“A close examination of the arguments made by [I-MAK and others] reveals that they fundamentally misrepresent the vital role patents play in promoting drug innovation without inhibiting generic entry.”
https://c4ip.org/fact-check-debunking-myths-about-patents-in-the-pharmaceutical-industry
DOFOLLOW
|
|
I-MAK Exposed - Setting the Record Straight on the Medical Innovation System
https://i-makexposed.com/
i-makexposed.com
|
— |
0 |
8 |
C4IP
"Keytruda's new formulation is not a case of patent abuse, but a demonstration of why patent rights matter: to fuel improvements that make life-saving medicines more humane, accessible, and sustainable for patients."
https://c4ip.org/why-continued-innovation-matters-keytruda-and-the-product-hopping-myth
DOFOLLOW
|
|
I-MAK Exposed - Setting the Record Straight on the Medical Innovation System
https://i-makexposed.com/
i-makexposed.com
|
— |
0 |
8 |
C4IP
"In a recent STAT article, I-MAK CEO Tahir Amin argues that abuses of the patent system are leading to higher drug costs. But this gets the logic exactly backwards — it is because of the patent system that the United States is the world leader in biopharmaceutical innovation."
https://c4ip.org/fact-check-weakening-the-patent-system-wont-lower-prices-for-patients-it-would-undermine-medical-progress
DOFOLLOW
|
|
I-MAK Exposed - Setting the Record Straight on the Medical Innovation System
https://i-makexposed.com/
i-makexposed.com
|
— |
0 |
8 |
Visit C4IP.ORG
https://c4ip.org/
DOFOLLOW
|
|
I-MAK Exposed - Setting the Record Straight on the Medical Innovation System
https://i-makexposed.com/
i-makexposed.com
|
— |
0 |
8 |
C4IP
“Follow-on patents have no effect on the lifespan of other patents – meaning that generic and biosimilar competition can still enter the market when the original patent expires.”
https://c4ip.org/fact-check-misguided-attacks-on-follow-on-patents-would-harm-patients
DOFOLLOW
|
|
I-MAK Exposed - Setting the Record Straight on the Medical Innovation System
https://i-makexposed.com/
i-makexposed.com
|
— |
0 |
8 |
C4IP
“The USPTO’s study refutes the common narrative that biopharma companies abuse patent protections to extend market exclusivity and reduce generic competition.”
https://c4ip.org/debunking-patent-disinformation-insights-from-the-usptos-drug-patent-and-exclusivity-study
DOFOLLOW
|